Acciones Cell MedX Corp. Other OTC
Acciones
CMXC
US15115X1072
Biotecnología e investigación médica
Ventas 2022 | 0,01 0,01 | Ventas 2023 | 0 0 | Capitalización | 6,29 mil 5,86 mil |
---|---|---|---|---|---|
Resultado Neto 2022 | - 0 | Resultado Neto 2023 | - 0 | VE / Ventas 2022 | 1.135.153.669 x |
Deuda neta 2022 | 592 mil 551 mil | Deuda neta 2023 | 903 mil 840 mil | VE / Ventas 2023 | 329.116.944 x |
P/E ratio 2022 |
-9,01
x | P/E ratio 2023 |
-0,01
x | Empleados | - |
Rendimiento 2022 * |
-
| Rendimiento 2023 |
-
| Flotante | 20,34 % |
Directores | Puesto | Edad | Desde |
---|---|---|---|
David Jeffs
CEO | Chief Executive Officer | 54 | 12/12 |
Yanika Silina
DFI | Director of Finance/CFO | 45 | 24/11/14 |
George Adams
CHM | Chairman | 76 | 23/03/18 |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
David Jeffs
CEO | Chief Executive Officer | 54 | 12/12 |
Dwayne Yaretz
BRD | Director/Board Member | 63 | 27/04/22 |
Joao da Costa
BRD | Director/Board Member | 59 | 08/06/20 |
Varia. 1 de ene. | Capi. | |
---|---|---|
+26,28 % | 48,09 mil M | |
-3,99 % | 40,43 mil M | |
+46,79 % | 40,62 mil M | |
-6,20 % | 28,36 mil M | |
+6,36 % | 24,89 mil M | |
-21,47 % | 19,01 mil M | |
+27,58 % | 12,09 mil M | |
-2,75 % | 11,8 mil M | |
-2,02 % | 11,88 mil M |